Cellectis S.A. (CLLS)

Market price: $1.26

6 methods not shown

• EV / EBITDA: EBITDA is non-positive — an EBITDA multiple yields no meaningful enterprise value (loss-making at the EBITDA line)
• EV / Revenue: the market prices this company far outside its sector's EV / Revenue range (its own multiple is 1.37 vs a sector band of 5.54–10.30) — a sector-average bar would be misleading here, so it is withheld
• EV / Gross Profit: no multiple band available for EV / Gross Profit — supplied with market data (peer comps / own history)
• P / E: diluted EPS is non-positive — P/E is not meaningful for a loss-making period
• P / B: the market prices this company far outside its sector's P / B range (its own multiple is 1.66 vs a sector band of 5.15–9.82) — a sector-average bar would be misleading here, so it is withheld
• DCF (FCFF): base unlevered FCF is non-positive (-33,177,176.06) — nothing to discount; a standard FCFF DCF does not apply

Pre-profit company — earnings-based methods not meaningful.

We can't show a valuation range for this company yet — we have its financial data, but not a peer group we can stand behind to compare it against, and the methods that apply here price a company against comparable companies.